Wanbury and Marksans Pharma Shares Decline Amid Mixed Healthcare Index Performance
Wanbury Ltd and Marksans Pharma Ltd both experienced declines in share prices, falling 6.43% and 5.24% respectively on the reported day. The BSE Healthcare index also dropped, with decreases of 0.22% and 1.34% noted in the two reports, despite showing monthly gains of around 3-5%. Over the past year, the healthcare index rose approximately 11%, outperforming the SENSEX, which fell by about 5%. Trading volumes for both stocks were below their monthly averages, and both hit record highs earlier in the year.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (50/100). Lens Score 37/100.
Outlets measured: businessstandard, businessstandard. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (50–50/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
businessstandard broke this story on 21 Jul, 05:11 am. Other outlets followed.
- 1